Colorectal carcinoma. A survey of 1345 cases 1950-1984 - PubMed (original) (raw)
- PMID: 4096172
Colorectal carcinoma. A survey of 1345 cases 1950-1984
U Ohman. Acta Chir Scand. 1985.
Abstract
A 35-year (1950-1984) experience of colorectal carcinoma is surveyed. Intendedly curative resection was performed in 941 (70%) of the 1345 patients, this proportion being constant throughout the study. The operative mortality was 4.6%, falling from 12% in the early 1950s to less than 1%. Five-year survival, calculated for 1066 patients seen in 1950-1979, was 35% overall and 49% after surgery with curative intent. Improved survival rates were mainly due to decline in operative mortality. In Dukes' stages A, B and C the respective 5-year rates were 83, 48 and 22%. Retention of the original Dukes' system is advocated. Further improvement in results probably cannot be achieved via surgical management. Intensive follow-up routines have not revealed significant numbers of curable recurrences, and adjuvant treatment has been disappointing. To improve the long-term prospects, earlier diagnosis seems to be essential. Screening for fecal occult blood may be valuable, but proof awaits the results of randomized clinical trials.
Similar articles
- Effect of occult hepatic metastases on survival after curative resection for colorectal carcinoma.
Finlay IG, McArdle CS. Finlay IG, et al. Gastroenterology. 1983 Sep;85(3):596-9. Gastroenterology. 1983. PMID: 6873606 - Carcinoma of the colon and rectum. Results of treatment in 284 cases.
Nilsson E, Gregersen NP, Hartvig B, Sjödahl R. Nilsson E, et al. Acta Chir Scand. 1984;150(2):177-82. Acta Chir Scand. 1984. PMID: 6202086 - Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report.
Tominaga T, Sakabe T, Koyama Y, Hamano K, Yasutomi M, Takahashi T, Kodaira S, Kato T, Ogawa N. Tominaga T, et al. Cancer. 1996 Aug 1;78(3):403-8. doi: 10.1002/(SICI)1097-0142(19960801)78:3<403::AID-CNCR4>3.0.CO;2-K. Cancer. 1996. PMID: 8697383 Clinical Trial. - [Surgery of loco-regional recurrences in colorectal cancer].
Peracchia A, Sarli L, Pietra N, Choua O, Maggiore SM. Peracchia A, et al. Ann Ital Chir. 1995 Jan-Feb;66(1):69-83. Ann Ital Chir. 1995. PMID: 7545359 Review. Italian. - [Results of chemotherapy in cancers of the colon].
Seitz JF, Rougier P. Seitz JF, et al. Bull Cancer. 1994 Apr;81(4):260-76. Bull Cancer. 1994. PMID: 7535602 Review. French.
Cited by
- Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial.
Laffer U, Metzger U, Aeberhard P, Lorenz M, Harder F, Maibach R, Zuber M, Herrmann R. Laffer U, et al. Int J Colorectal Dis. 2008 Dec;23(12):1233-41. doi: 10.1007/s00384-008-0543-8. Epub 2008 Aug 8. Int J Colorectal Dis. 2008. PMID: 18688620 Clinical Trial. - Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
Ganesh S, Sier CF, Heerding MM, van Krieken JH, Griffioen G, Welvaart K, van de Velde CJ, Verheijen JH, Lamers CB, Verspaget HW. Ganesh S, et al. Br J Cancer. 1997;75(12):1793-801. doi: 10.1038/bjc.1997.306. Br J Cancer. 1997. PMID: 9192984 Free PMC article. - Early detection of liver metastasis in patients with colorectal carcinoma by increased levels of circulating IgA- and IgM-associated secretory component.
Kvale D, Rognum TO, Brandtzaeg P. Kvale D, et al. Br J Cancer. 1987 Nov;56(5):629-32. doi: 10.1038/bjc.1987.256. Br J Cancer. 1987. PMID: 3426927 Free PMC article.